ACE2 and COVID-19: The fecal samples of patients with COVID-19 contained Bacteroides species capable of downregulating ACE2 expression in the murine gut; this alteration could increase the accessibility of the intestinal epithelial cells to SARS-CoV-2 [121], and the bacterium Firmicutes (Erysipelotrichaceae), which demonstrates a positive correlation in the murine gut.